Investigacion Independiente

Investigacion Independiente is a prominent Mexican contract research organization (CRO) and clinical research site dedicated to the management and execution of Phase I-IV clinical trials. Established in 1993, the company serves as a strategic partner for international pharmaceutical and biotechnology firms seeking to conduct clinical research in Latin America. They offer a full suite of services including site selection, patient recruitment, and regulatory compliance, with a strong focus on therapeutic areas such as oncology, endocrinology, and cardiology. The organization is recognized for its commitment to Good Clinical Practice (GCP) standards and its role in advancing clinical development within the Mexican healthcare ecosystem. By leveraging its extensive network and local expertise, the company facilitates the efficient delivery of high-quality clinical data for global drug development programs.